Cilostazol was effective for capsular warning syndrome during anticoagulant therapy: a case report
-
- M.D. Kawatake Ayane
- Department of Stroke and Cerebrovascular Medicine, Kyorin University
-
- M.D., Ph.D. Kawano Hiroyuki
- Department of Stroke and Cerebrovascular Medicine, Kyorin University
-
- M.D., Ph.D. Honda Yuko
- Department of Stroke and Cerebrovascular Medicine, Kyorin University
-
- M.D., Ph.D. Unno Yoshiko
- Department of Stroke and Cerebrovascular Medicine, Kyorin University
-
- M.D., Ph.D. Hirano Teruyuki
- Department of Stroke and Cerebrovascular Medicine, Kyorin University
Bibliographic Information
- Other Title
-
- 抗凝固療法中に発症したCapsular warning syndromeに対してシロスタゾール追加が有効であった1例
Abstract
<p>An 88-year-old woman with atrial fibrillation was admitted to our hospital due to the right hemiplegia and aphasia. MRA shows the left middle cerebral artery M2 occlusion. After intravenous rt-PA, her symptoms improved. She was diagnosed with cardioembolic stroke, and was treated with direct oral anticoagulation therapy. However, she had repeated stereotypical transient right hemiparesis a week after index stroke. Her symptoms were considered capsular warning syndrome (CWS). After cilostazol was administered, no further transient neurological deteriorations occurred. CWS can coexist with acute cardioembolic stroke, and cilostazol was effective.</p>
Journal
-
- Rinsho Shinkeigaku
-
Rinsho Shinkeigaku 64 (3), 181-184, 2024
Societas Neurologica Japonica